The present invention relates to the use of novel macrocyclic compounds of Formula I,
wherein the variables Q, Q
1
, Q
2
, Q
3
, and Q
4
are defined as described herein, which inhibit JAK and are useful for the treatment of auto-immune and inflammatory diseases.
Novel Inhibitors of Proliferation and Activation of Signal Transducer and Activator of Transcription (STATS)
申请人:Priebe Waldemar
公开号:US20110053992A1
公开(公告)日:2011-03-03
Pyridine compounds effective in modulation STAT3 and/or STAT5 activation are provided that are useful in the prevention and treatment of proliferative disease and conditions including cancer, inflammation and proliferative skin disorders.
NOVEL INHIBITORS OF PROLIFERATION AND ACTIVATION OF SIGNAL TRANSDUCER AND ACTIVATORS OF TRANSCRIPTION (STATS)
申请人:Priebe Waldemar
公开号:US20120149738A1
公开(公告)日:2012-06-14
Pyridine compounds effective in modulation STAT3 and/or STAT5 activation are provided that are useful in the prevention and treatment of proliferative disease and conditions including cancer, inflammation and proliferative skin disorders.
NOVEL INHIBITORS OF PROLIFERATION AND ACTIVATION OF SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION (STATS)
申请人:Board of Regents, The University of Texas System
公开号:US20140228414A1
公开(公告)日:2014-08-14
Pyridine compounds effective in modulation STAT3 and/or STAT5 activation are provided that are useful in the prevention and treatment of proliferative disease and conditions including cancer, inflammation and proliferative skin disorders.
Inhibitors of proliferation and activation of signal transducer and activators of transcription (STATS)
申请人:Priebe Waldemar
公开号:US08637675B2
公开(公告)日:2014-01-28
Pyridine compounds effective in modulation STAT3 and/or STAT5 activation are provided that are useful in the prevention and treatment of proliferative disease and conditions including cancer, inflammation and proliferative skin disorders.